WebMay 30, 2024 · US Patent 9,663,763 was examined under the Cancer Immunotherapy Pilot Program, also known as the “Patents 4 Patients” initiative, and is the third patent in Celyad’s allogeneic intellectual ... WebThe new Cancer Moonshot Pilot Program is scheduled to run until either January 31, 2025, or the date by which we accept a total of 1,000 grantable petitions (whichever is earlier).
UPSTO Extends Pilot Programs Foley & Lardner LLP
WebFor questions regarding a Cancer Moonshot Expedited Examination Pilot Program petition, please contact: Gary B. Nickol, Supervisory Patent Examiner, Technology Center 1600, … WebJul 12, 2016 · The Cancer Immunotherapy Pilot Program will run 12 months until June 29, 2024. Applicants who are interested in participating in the program should file a petition to make special under the Cancer Immunotherapy Pilot Program. Requirements for participating in the program are as follows: Type of Application. The application must be … solgar gtf chromium
Expedited Examination Programs at the USPTO: What …
Web(USPTO) implemented the Cancer Immunotherapy Pilot Program in support of the White House’s National Cancer Moonshot initiative, which sought to accelerate cancer research. The program permits patent applications pertaining to cancer immunotherapy to be advanced out of turn for examination. To date, over 835 petitions requesting participation WebJul 8, 2016 · Effective June 29, 2016, the United States Patent and Trademark Office (USPTO) implemented a pilot program to provide for earlier review of patent applications pertaining to cancer immunotherapy. The Cancer Immunotherapy Pilot Program was established in support of the White House national $1 billion initiative to achieve ten … WebJul 9, 2016 · Effective June 29, 2016, the United States Patent and Trademark Office (USPTO) implemented a pilot program to provide for earlier review of patent applications pertaining to cancer immunotherapy ... solgar fish oil review